ClōSYS Ultra Sensitive Oral Rinse Lab Tested on Influenza A Virus
There are two main types of influenza virus, influenza A and influenza B. According to data collected in recent years by the Centers for Disease Control and Prevention (CDC), influenza A H3N2 is the dominant virus and tends to be more severe.
ClōSYS initiated in vitro lab tests with Influenza A H3N2, to understand if our patented antimicrobial formula is helpful in fighting the infectious virus. Further studies in the mouth are needed and in progress. - View Press Release
NOTE: CloSYS Products have NOT been proven to help mitigate, prevent, treat diagnose or cure the Influenza A virus. Lab tests are just the first steps in learning more.
ClōSYS Ultra Sensitive Rinse, ClōSYS Sensitive Rinse, & ClōSYS Oral Spray Lab Tested on COVID-19 virus
Because the COVID-19 virus can be transmitted from spray droplets from the mouth, oral care companies are being asked if their products help reduce the spread of this virus. So we're working to learn more. - View Press Release
As ClōSYS is an excellent antimicrobial for oral care we initiated the first step lab tests to understand if our patented formula might be helpful reducing the viral load of saliva thus potentially lowering the transmission of the COVID-19 virus. Further studies in the mouth are needed and in progress.
NOTE: CloSYS Products have NOT been proven to help mitigate, prevent, treat diagnose or cure the COVID-19 virus. Lab tests are just the first steps in learning more.
ClōSYS is committed to helping people get well and stay well.
We will continue to follow the science in oral care, be transparent in our research, and share our findings.
